Compare Bristol-Myers Squibb Co (BMY) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Wayfair Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.59 (market cap $129.94B), while Wayfair Inc trades at $104.76 (market cap $14.14B). The key difference: Bristol-Myers Squibb Co is far larger — about 9.2× Wayfair Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals.
| BMY | W | |
|---|---|---|
Market Cap | $129.94B | $14.14B |
Sector | Health | Consumer Cyclical |
52-Week High | $65.89 | $119.05 |
52-Week Low | $42.60 | $57.40 |
Enterprise Value | $163.92B | $16.47B |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
